CD38 and HLA‐DR are markers for CD8 T‐cell activation, and an accumulated activation of HLA‐DR is associated with severe COVID‐19 (Neidleman et al., 2021; Quinn et al., 2018). The gene discussed is CD8A; the disease is COVID-19.